|
1
|
Brodeur GM: Neuroblastoma: Biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnsen JI, Dyberg C, Fransson S and
Wickström M: Molecular mechanisms and therapeutic targets in
neuroblastoma. Pharmacol Res. 131:164–176. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnsen JI, Kogner P, Albihn A and
Henriksson MA: Embryonal neural tumours and cell death. Apoptosis.
14:424–438. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ratner N, Brodeur GM, Dale RC and Schor
NF: The ‘neuro’ of neuroblastoma: Neuroblastoma as a
neurodevelopmental disorder. Ann Neurol. 80:13–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Davidoff AM: Neuroblastoma. Semin Pediatr
Surg. 21:2–14. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matthay KK, Maris JM, Schleiermacher G,
Nakagawara A, Mackall CL, Diller L and Weiss WA: Neuroblastoma. Nat
Rev Dis Primers. 2:160782016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen AM, Trout AT and Towbin AJ: A review
of neuroblastoma image-defined risk factors on magnetic resonance
imaging. Pediatr Radiol. 48:1337–1347. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cohn SL, Pearson AD, London WB, Monclair
T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, et
al: The international neuroblastoma risk group (INRG)
classification system: An INRG task force report. J Clin Oncol.
27:289–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luksch R, Castellani MR, Collini P, De
Bernardi B, Conte M, Gambini C, Gandola L, Garaventa A, Biasoni D,
Podda M, et al: Neuroblastoma (peripheral neuroblastic tumours).
Crit Rev Oncol Hematol. 107:163–181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gonzalez Malagon SG and Liu KJ: ALK and
GSK3: Shared features of neuroblastoma and neural crest cells. J
Exp Neurosci. 12:11790695187924992018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Westermark UK, Wilhelm M, Frenzel A and
Henriksson MA: The MYCN oncogene and differentiation in
neuroblastoma. Semin Cancer Biol. 21:256–266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bell E, Chen L, Liu T, Marshall GM, Lunec
J and Tweddle DA: MYCN oncoprotein targets and their therapeutic
potential. Cancer Lett. 293:144–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cruickshank JM: The role of beta-blockers
in the treatment of hypertension. Adv Exp Med Biol. 956:149–166.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tank AW and Lee Wong D: Peripheral and
central effects of circulating catecholamines. Compr Physiol.
5:1–15. 2015.PubMed/NCBI
|
|
15
|
Lukewich MK, Rogers RC and Lomax AE:
Divergent neuroendocrine responses to localized and systemic
inflammation. Semin Immunol. 26:402–408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Padro CJ and Sanders VM: Neuroendocrine
regulation of inflammation. Semin Immunol. 26:357–368. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shakola F, Suri P and Ruggiu M: Splicing
regulation of pro-inflammatory cytokines and chemokines: At the
interface of the neuroendocrine and immune systems. Biomolecules.
5:2073–2100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lan H, Hoos LM, Liu L, Tetzloff G, Hu W,
Abbondanzo SJ, Vassileva G, Gustafson EL, Hedrick JA and Davis HR:
Lack of FFAR1/GPR40 does not protect mice from high-fat
diet-induced metabolic disease. Diabetes. 57:2999–3006. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim-Fuchs C, Le CP, Pimentel MA,
Shackleford D, Ferrari D, Angst E, Hollande F and Sloan EK: Chronic
stress accelerates pancreatic cancer growth and invasion: A
critical role for beta-adrenergic signaling in the pancreatic
microenvironment. Brain Behav Immun. 40:40–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Payne JK: State of the science: Stress,
inflammation, and cancer. Oncol Nurs Forum. 41:533–540. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dal Monte M, Casini G, Filippi L, Nicchia
GP, Svelto M and Bagnoli P: Functional involvement of
beta3-adrenergic receptors in melanoma growth and vascularization.
J Mol Med (Berl). 91:1407–1419. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen H, Liu D, Yang Z, Sun L, Deng Q, Yang
S, Qian L, Guo L, Yu M, Hu M, et al: Adrenergic signaling promotes
angiogenesis through endothelial cell-tumor cell crosstalk. Endocr
Relat Cancer. 21:783–795. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen D, Xing W, Hong J, Wang M, Huang Y,
Zhu C, Yuan Y and Zeng W: The beta2-adrenergic receptor is a
potential prognostic biomarker for human hepatocellular carcinoma
after curative resection. Ann Surg Oncol. 19:3556–3565. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu FQ, Fang T, Yu LX, Lv GS, Lv HW, Liang
D, Li T, Wang CZ, Tan YX, Ding J, et al: ADRB2 signaling promotes
HCC progression and sorafenib resistance by inhibiting autophagic
degradation of HIF1α. J Hepatol. 65:314–324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Magnon C, Hall SJ, Lin J, Xue X, Gerber L,
Freedland SJ and Frenette PS: Autonomic nerve development
contributes to prostate cancer progression. Science.
341:12363612013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Barron TI, Connolly RM, Sharp L, Bennett K
and Visvanathan K: Beta blockers and breast cancer mortality: A
population-based study. J Clin Oncol. 29:2635–2644. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grytli HH, Fagerland MW, Fossa SD and
Tasken KA: Association between use of beta-blockers and prostate
cancer-specific survival: A cohort study of 3561 prostate cancer
patients with high-risk or metastatic disease. Eur Urol.
65:635–641. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Efeyan A, Comb WC and Sabatini DM:
Nutrient-sensing mechanisms and pathways. Nature. 517:302–310.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang X, Overholtzer M and Thompson CB:
Autophagy in cellular metabolism and cancer. J Clin Invest.
125:47–54. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wirawan E, Vanden Berghe T, Lippens S,
Agostinis P and Vandenabeele P: Autophagy: For better or for worse.
Cell Res. 22:43–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Scrivo A, Bourdenx M, Pampliega O and
Cuervo AM: Selective autophagy as a potential therapeutic target
for neurodegenerative disorders. Lancet Neurol. 17:802–815. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim KH and Lee MS: Autophagy - a key
player in cellular and body metabolism. Nat Rev Endocrinol.
10:322–337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Menzies FM, Fleming A, Caricasole A, Bento
CF, Andrews SP, Ashkenazi A, Fullgrabe J, Jackson A, Jimenez
Sanchez M, Karabiyik C, et al: Autophagy and neurodegeneration:
Pathogenic mechanisms and therapeutic opportunities. Neuron.
93:1015–1034. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mizushima N: A(beta) generation in
autophagic vacuoles. J Cell Biol. 171:15–17. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo JY, Karsli-Uzunbas G, Mathew R, Aisner
SC, Kamphorst JJ, Strohecker AM, Chen G, Price S, Lu W, Teng X, et
al: Autophagy suppresses progression of K-ras-induced lung tumors
to oncocytomas and maintains lipid homeostasis. Genes Dev.
27:1447–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mathew R, Karp CM, Beaudoin B, Vuong N,
Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, et al:
Autophagy suppresses tumorigenesis through elimination of p62.
Cell. 137:1062–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dower CM, Bhat N, Gebru MT, Chen L, Wills
CA, Miller BA and Wang HG: Targeted inhibition of ULK1 promotes
apoptosis and suppresses tumor growth and metastasis in
neuroblastoma. Mol Cancer Ther. 17:2365–2376. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Russell RC, Tian Y, Yuan H, Park HW, Chang
YY, Kim J, Kim H, Neufeld TP, Dillin A and Guan KL: ULK1 induces
autophagy by phosphorylating Beclin-1 and activating VPS34 lipid
kinase. Nat Cell Biol. 15:741–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Seok S, Fu T, Choi SE, Li Y, Zhu R, Kumar
S, Sun X, Yoon G, Kang Y, Zhong W, et al: Transcriptional
regulation of autophagy by an FXR-CREB axis. Nature. 516:108–111.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mierke CT: The fundamental role of
mechanical properties in the progression of cancer disease and
inflammation. Rep Prog Phy. 77:0766022014. View Article : Google Scholar
|
|
42
|
Creed SJ, Le CP, Hassan M, Pon CK, Albold
S, Chan KT, Berginski ME, Huang Z, Bear JE, Lane JR, et al:
β2-adrenoceptor signaling regulates invadopodia formation to
enhance tumor cell invasion. Breast Cancer Res. 17:1452015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mowers EE, Sharifi MN and Macleod KF:
Autophagy in cancer metastasis. Oncogene. 36:1619–1630. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang A, Herter-Sprie G, Zhang H, Lin EY,
Biancur D, Wang X, Deng J, Hai J, Yang S, Wong KK, et al: Autophagy
sustains pancreatic cancer growth through both cell-autonomous and
nonautonomous mechanisms. Cancer Discov. 8:276–287. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cai J, Li R, Xu X, Zhang L, Lian R, Fang
L, Huang Y, Feng X, Liu X, Li X, et al: CK1α suppresses lung tumour
growth by stabilizing PTEN and inducing autophagy. Nat cell Biol.
20:465–478. 2018. View Article : Google Scholar : PubMed/NCBI
|
